Bing‐Hua Jiang
Impact in
- Cancer Research top 0.01%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 0.05%
- Angiogenesis and VEGF in Cancer
- RNA modifications and cancer
- Circular RNAs in diseases
- Mitochondrial Function and Pathology
Papers in
- Cancer Research 135
- Cancer, Hypoxia, and Metabolism 63
- MicroRNA in disease regulation 59
- Cancer-related molecular mechanisms research 30
-
- Circular RNAs in diseases 29
- RNA modifications and cancer 29
- Epigenetics and DNA Methylation 24
- PI3K/AKT/mTOR signaling in cancer 20
- Co-authors
- Gregg L. SemenzaLiu LFaton AganiSandra W. LeungNarayan V. IyerJenny Z. ZhengRobert D. KoosPeter K. Vogt
- Journals
- Journal of Biological Chemistry (12 papers)Biochemical and Biophysical Research Communications (10 papers)Oncotarget (10 papers)PLoS ONE (7 papers)Oncogene (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Bing‐Hua Jiang
303 papers receiving 31.2k citations
Hit Papers
Peers
Comparison fields: 5 of 189
- Cancer Research 16.2k
- Molecular Biology 19.5k
- Biochemistry 1.1k
- Oncology 4.0k
- Immunology 2.4k
Countries citing papers authored by Bing‐Hua Jiang
This map shows the geographic impact of Bing‐Hua Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing‐Hua Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing‐Hua Jiang more than expected).
Fields of papers citing papers by Bing‐Hua Jiang
This network shows the impact of papers produced by Bing‐Hua Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing‐Hua Jiang. The network helps show where Bing‐Hua Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing‐Hua Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 10 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 30 | |
| 11 | 2021 | 10 | |
| 12 | 2017 | 13 | |
| 13 | 2016 | 25 | |
| 14 | 2007 | 407 | |
| 15 | 2005 | 25 | |
| 16 | 2004 | 36 | |
| 17 | 2004 | 41 | |
| 18 | 2000 | 18 | |
| 19 | 2000 | 99 | |
| 20 | Activation of Vascular Endothelial Growth Factor Gene Transcription by Hypoxia-Inducible Factor 1 Hit paper breakdown → | 1996 | 3233 |
About Bing‐Hua Jiang
Bing‐Hua Jiang is a scholar working on Cancer Research, Molecular Biology, Oncology, Biochemistry and Health, Toxicology and Mutagenesis, having authored 313 papers that have together received 31.7k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (63 papers), MicroRNA in disease regulation (59 papers), Cancer-related molecular mechanisms research (30 papers), Circular RNAs in diseases (29 papers), RNA modifications and cancer (29 papers), Epigenetics and DNA Methylation (24 papers), PI3K/AKT/mTOR signaling in cancer (20 papers) and Cancer-related Molecular Pathways (15 papers). The work is most often cited by research in Cancer Research (16.2k citations), Molecular Biology (19.5k citations), Biochemistry (1.1k citations), Oncology (4.0k citations) and Immunology (2.4k citations). Bing‐Hua Jiang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Gregg L. Semenza, Liu L, Faton Agani, Sandra W. Leung, Narayan V. Iyer, Jenny Z. Zheng, Robert D. Koos, Peter K. Vogt, Jing Fang and Xianglin Shi. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications, Oncotarget, PLoS ONE and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.